Impact of Birth Method on Baby Gut Bacteria and Pain Sensitivity
Official title: The Role of Alterations in Trophic Cooperation Early in Life on Visceral Sensitivity
Run by Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · NCT07899333 · Data updated 2026-11-12
This observational study looks at how being born vaginally or by cesarean section influences a newborn’s gut microbiome, immune development, gut function, and sensitivity to abdominal pain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Days to 4 Days |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement Academic / other |
| Locations | 1 site (Orsay) |
| Status | Recruiting |
| Started | October 26, 2026 |
| Main results expected | October 2030 |
| Study ends | October 2030 |
| Registry record updated | October 28, 2026 |
| Trial ID | NCT07899333 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy newborns aged 2–4 days born vaginally or by cesarean section, exclusively breastfed, with mothers meeting all eligibility criteria and giving informed consent.
✕Probably not a fit
Babies with medical conditions, those not exclusively breastfed, or whose mothers used antibiotics, probiotics, or had gestational diabetes may not experience the same insights.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study follows healthy newborns to see how delivery method alters the early gut microbiome and related systems. Data will be collected from baby stool and clinical assessments to explore links between microbiota composition, immune markers, and visceral sensitivity. The researchers will compare vaginally delivered and cesarean-born infants who are exclusively breastfed and meet other eligibility criteria. No interventions are applied; the study observes natural differences in early life microbial establishment. Findings may help clarify how birth mode affects long-term gut health and immune development.
Why it matters
Potential benefit: If successful, results could improve understanding of how birth method shapes infant gut development and immune function, potentially guiding safer approaches to support gut health.
How similar studies have gone: Previous research has shown associations between delivery mode and early gut microbiota differences, supporting the relevance of this observational approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria of the babies : * 2 to 4 days old * Born vaginally or by cesarean section * Gestational age at birth ≥ 37 weeks of amenorrhea * Exclusively breastfed * With no known medical conditions * Not receiving any medical supplements other than standard vitamins * Whose mothers did not take antibiotics during the third trimester of pregnancy, other than those administered at the time of the cesarean section * Whose mothers did not take probiotics during the third trimester of pregnancy * Whose mothers did not have gestational diabetes * Whose mothers do not have any known chronic medical conditions * Whose mothers did not undergo any chronic treatment * Whose mothers had a body mass index (BMI) below 25 at the start of pregnancy * Whose mothers provided consent to participate in the study and to have their babies' stool samples collected * Whose mothers are not deprived of their liberty or under legal guardianship Exclusion Criteria of the babies : * Older than 4 days * Born before 37 weeks of gestation * Not exclusively breastfed * Receiving medical supplementation other than conventional vitamins * With any type of medical condition * Whose mothers are under 18 years of age * Whose mothers received antibiotic therapy during the third trimester of pregnancy * Whose mothers took probiotics during the third trimester of pregnancy * Whose mothers have a chronic illness * Whose mothers are undergoing chronic treatment * Whose mothers developed gestational diabetes * Whose mothers had a BMI greater than 25 at the start of pregnancy * Whose mothers did not give consent to participate in the collection of their baby's stool samples * Whose mothers are deprived of their liberty or under legal guardianship
Where it's running
-
Hopital Paris-Saclay (GHNE)
Orsay, France Recruiting
Study contacts
- Principal investigator: Julie Poline — Hopital Paris-Saclay (GHNE)
- Study coordinator: REBECA MARTIN-ROSIQUE, PhD
- Email: rebeca.martin-rosique@inrae.fr
- Phone: +33 1 34 65 20 98
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploring how synbiotics can modify the microbiota in newborns exposed to antibiotics
This study is testing if giving a special supplement to newborns who received antibiotics can change their gut bacteria and help lower their chances of obesity and other health issues later on.
-
Probiotic supplement in healthy infants to study gut microbiota and immune function
Giving a probiotic to healthy infants from birth up to 6 months old to see how it affects their gut bacteria and immune health.
-
Growth, tolerance, and gut markers in healthy infants given dietary supplements
This study tests whether giving probiotic supplements to healthy newborns helps with weight gain and gut health compared with a placebo.
-
Preventing excessive crying and colic in newborns with a probiotic supplement of two L. reuteri strains
This will try giving healthy newborns a dietary supplement containing two L. reuteri probiotic strains plus vitamin D during their first three months to see if it reduces excessive crying and infantile colic compared with a placebo.
-
Dietary supplement in healthy infants
A double-blind, placebo-controlled study is testing whether a dietary supplement given to healthy term infants can change their gut microbiome compared with a placebo.
-
Effect of a New Infant Formula on Gut Health in Healthy Infants
A healthy, full-term infant formula is tested to see if it increases the good gut bacteria (Bifidobacterium) after 10 weeks compared with a standard formula.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.